Verition Fund Management’s CONMED CNMD Stock Holding History

Verition Fund Management’s Portfolio CNMD Stock Details CNMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q4	–	Sell	-3,500	Closed	-$337K	–	1111
2019 Q3	$337K	Buy	+3,500	New	+$329K	0.01%	770

Other funds holding CNMD

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

EARNEST Partners Atlanta, Georgia $27.7B AUM 52.44% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Fuller & Thaler Asset Management San Mateo, California $36.7B AUM 74.15% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

SEI Investments Oaks, Pennsylvania $113B AUM 34.64% 1-Year Est. Return

ICM

Invenomic Capital Management Boston, Massachusetts $1.67B AUM 1.43% 1-Year Est. Return

Verition Fund Management's CNMD Position: Q2 2026 in Review

Verition Fund Management sold out of CONMED (CNMD) in Q2 2026, closing a stake of 7,940 shares — an estimated $281K sold.

Verition Fund Management first reported a position in CNMD in Q2 2019 and held it in 19 quarters. The position peaked at $9.36M in Q2 2021. 246 funds tracked by Wall St. Rank hold CNMD as of Q2 2026.

Verition Fund Management reported no remaining CONMED position as of Q2 2026 after selling out during the quarter.
Verition Fund Management sold 7,940 CONMED shares in Q2 2026, an estimated $281K.
Verition Fund Management first reported a position in CONMED in Q2 2019 and held it in 19 quarters.
Verition Fund Management's CONMED position peaked at $9.36M in Q2 2021.
246 funds tracked by Wall St. Rank held CONMED as of Q2 2026.

Based on Verition Fund Management's 13F filing for Q2 2026, filed 14 Aug 2026.